Literature DB >> 28571159

Anaplastic Pleomorphic Xanthoastrocytoma in a Case of Neurofibromatosis Type 1: A Case Report.

K Thara1, Reetika Sharma2, G Thiagarajan3, Anita Ramdas4, Renu Gboy Varghese4.   

Abstract

Pleomorphic Xanthoastrocytoma (PXA) is a rare brain tumour comprising only <1% of primary brain tumours which is seen in children and young adults. Only 9-20% of the PXA shows anaplastic features and this has a bad prognosis. PXA is a WHO grade II tumour while anaplastic PXA is a WHO grade III tumour. Neurofibromatosis type 1(NF1), which is an autosomal dominant condition, predisposes to tumours of the central nervous system; most of which are pilocytic astrocytomas. Association of PXA with NF1 is very rare and only a very few cases have been reported. Here, we present a case of 42-year-old male, a known case of NF1, with multiple neurofibromas, who presented with right sided hemiparesis, seizures and vomiting. The histopathology and immunohistochemistry features were suggestive of anaplastic PXA.

Entities:  

Keywords:  Central nervous system tumour; Glioblastoma; High grade; Immunohistochemistry

Year:  2017        PMID: 28571159      PMCID: PMC5449805          DOI: 10.7860/JCDR/2017/26685.9713

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  6 in total

Review 1.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

2.  Multicentric pleomorphic xanthoastrocytoma in a patient with neurofibromatosis type 1. Case report and review of the literature.

Authors:  Stephan Saikali; Anne Le Strat; Anne Heckly; Nathalie Stock; Jean-Marie Scarabin; Abderrahmane Hamlat
Journal:  J Neurosurg       Date:  2005-02       Impact factor: 5.115

3.  Cerebellar hemisphere, an uncommon location for pleomorphic xanthoastrocytoma and lipidized glioblastoma multiformis.

Authors:  S Kumar; T M Retnam; G Menon; S Nair; R N Bhattacharya; V V Radhakrishnan
Journal:  Neurol India       Date:  2003-06       Impact factor: 2.117

4.  Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin.

Authors:  Hilda Martinez-Diaz; B K Kleinschmidt-DeMasters; Suzanne Z Powell; Anthony T Yachnis
Journal:  Arch Pathol Lab Med       Date:  2003-09       Impact factor: 5.534

Review 5.  Cerebellar pleomorphic xanthoastrocytoma in a patient with neurofibromatosis type 1: a case report and literature review.

Authors:  Hidehiro Takei; Emilie Rouah; Meenakshi B Bhattacharjee
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  Pleomorphic xanthoastrocytoma with anaplastic features: a case report.

Authors:  Sadiya Niamathullah; S Sivaselvam; Mitra Ghosh; Siddhartha Ghosh
Journal:  Indian J Pathol Microbiol       Date:  2014 Jan-Mar       Impact factor: 0.740

  6 in total
  3 in total

Review 1.  An update on the central nervous system manifestations of neurofibromatosis type 1.

Authors:  J Stephen Nix; Jaishri Blakeley; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2019-04-08       Impact factor: 17.088

2.  Epilepsy in NF1: a systematic review of the literature.

Authors:  Pia Bernardo; Giuseppe Cinalli; Claudia Santoro
Journal:  Childs Nerv Syst       Date:  2020-07-01       Impact factor: 1.475

3.  Pleomorphic Xanthoastrocytoma of the Pineal Region in a Pediatric Patient With Neurofibromatosis Type 1.

Authors:  Joshua A Hanna; Mansour Mathkour; Edna E Gouveia; JonMark Lane; Lauren Boehm; Joseph R Keen; Erin E Biro; Olawale A Sulaiman; Cuong J Bui
Journal:  Ochsner J       Date:  2020
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.